ImmunogenX

Advancing celiac disease management with Latiglutenase therapy, innovative diagnostic tools, and pioneering gluten detection methods.

General Information
Company Name
ImmunogenX
Founded Year
2013
Location (Offices)
Founders / Decision Makers
Number of Employees
-
Industries
Biotechnology, Health Care
Funding Stage
Grant
Social Media

ImmunogenX - Company Profile

ImmunogenX® is a clinical-stage biotherapeutics company established in 2013, dedicated to advancing celiac disease management. Their flagship product, Latiglutenase, shows promise in revolutionizing the treatment of celiac disease. Supported by leading experts in celiac disease research, ImmunogenX is also developing CypCel™, a minimally-invasive diagnostic tool to monitor celiac disease management. This innovative tool will utilize a clinically meaningful metabolic marker to assess the recovery status of patients undergoing gluten-free diets or other treatments. In addition to therapeutics and diagnostics, ImmunogenX is working on enhancing food safety by employing advanced mass spectrometry techniques to detect and quantify critical gluten peptide sequences found in wheat, barley, and rye. The most recent investment in ImmunogenX was a grant investment received on 11 April 2019 from the National Institute of Allergy and Infectious Diseases. As a company operating within the Biotechnology and Health Care industries, ImmunogenX is positioned at the forefront of advancing celiac disease treatment and diagnosis. Their commitment to innovation in therapy, diagnostics, and food safety for celiac patients makes them a noteworthy player in the biotech landscape.

Taxonomy: Celiac disease, Latiglutenase therapy, Biotherapeutics, Diagnostic tools, Gluten detection, ImmunogenX, Clinical-stage, Mass spectrometry, Food safety

Funding Rounds & Investors of ImmunogenX (1)

View All
Funding Stage Amount No. Investors Investors Date
Grant Unknown 1 National Institute of Allergy and Infectious Diseases 11 Apr 2019

Latest News of ImmunogenX

View All

No recent news or press coverage available for ImmunogenX.

Similar Companies to ImmunogenX

View All
TheDr.com - Similar company to ImmunogenX
TheDr.com Making it Easy to Do the Right Thing
Beyond Celiac - Similar company to ImmunogenX
Beyond Celiac Accelerating celiac disease research.
ImmusanT - Similar company to ImmunogenX
ImmusanT Pioneering advancements for celiac disease through innovative diagnostics and therapeutic solutions
PvP Biologics, Inc. - Similar company to ImmunogenX
PvP Biologics, Inc. Novel Therapeutics for Celiac Disease